Hepatitis C Virus-Induced Insulin Resistance: Not All Genotypes Are the Same

Gastroenterology

Volumn 134, Issue 2, 2008, Pages 619-622

  Neuschwander Tetri, Brent A ^a  

^a Saint Louis University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; EDITORIAL; GENOTYPE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LIVER BIOPSY; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL;

EID: 38649126192     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.12.041     Document Type: Editorial

References (24)

1. Hui J.M., Sud A., Farrell G.C., et al. Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression. Gastroenterology 125 (2003) 1695-1704
2. Mehta S.H., Brancati F.L., Strathdee S.A., et al. Hepatitis C virus infection and incident type 2 diabetes. Hepatology 38 (2003) 50-56
3. Shintani Y., Fujie H., Miyoshi H., et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 126 (2004) 840-848
4. Kawaguchi T., Ide T., Taniguchi E., et al. Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2. Am J Gastroenterol 102 (2007) 570-576
5. Wang C.-S., Wang S.-T., Yao W.-J., et al. Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study. Am J Epidemiol 166 (2007) 196-203
6. Moucari R., Asselah T., Cazals-Hatem D., et al. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology 134 (2008) 416-423
7. Katz A., Nambi S.S., Mather K., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85 (2000) 2402-2410
8. Marchesini G., Brizi M., Bianchi G., et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50 (2001) 1844-1850
9. Ratziu V., Heurtier A., Bonyhay L., et al. Review article: an unexpected virus-host interaction-the hepatitis C virus-diabetes link. Aliment Pharmacol Ther 22 Suppl 2 (2005) 56-60
10. Zekry A., McHutchison J.G., and Diehl A.M. Insulin resistance and steatosis in hepatitis C virus infection. Gut 54 (2005) 903-906
11. Lai M.M. Hepatitis C virus proteins: direct link to hepatic oxidative stress, steatosis, carcinogenesis and more. Gastroenterology 122 (2002) 568-571
12. Abid K., Pazienza V., de Gottardi A., et al. An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation. J Hepatol 42 (2005) 744-751
13. Romero-Gómez M., Castellano-Megias V.M., Grande L., et al. Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C. Am J Gastroenterol 98 (2003) 1135-1141
14. Hui J.M., Kench J., Farrell G.C., et al. Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection. J Gastroenterol Hepatol 17 (2002) 873-881
15. den Boer M., Voshol P.J., Kuipers F., et al. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models. Arterioscler Thromb Vasc Biol 24 (2004) 644-649
16. Ryysy L., Häkkinen A.M., Goto T., et al. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 49 (2000) 749-758
17. Buettner R., Ottinger I., Scholmerich J., et al. Preserved direct hepatic insulin action in rats with diet-induced hepatic steatosis. Am J Physiol Endocrinol Metab 286 (2004) E828-E833
18. Monetti M., Levin M.C., Watt M.J., et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab 6 (2007) 69-78
19. Weinman S.A., and Belalcazar L.M. Hepatitis C: a metabolic liver disease. Gastroenterology 126 (2004) 917-919
20. Moriishi K., Okabayashi T., Nakai K., et al. Proteasome activator PA28g-dependent nuclear retention and degradation of hepatitis C virus core protein. J Virol 77 (2003) 10237-10249
21. Miyamoto H., Moriishi K., Moriya K., et al. Involvement of the PA28g-dependent pathway in insulin resistance induced by hepatitis C virus core protein. J Virol 81 (2007) 1727-1735
22. Kawaguchi T., Yoshida T., Harada M., et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 165 (2004) 1499-1508
23. Aytug S., Reich D., Sapiro L.E., et al. Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology 38 (2003) 1384-1392
24. Harrison S.A., Brunt E.M., Qazi R.A., et al. Effect of significant histologic steatosis or steatohepatitis on response to antiviral therapy in patients with chronic hepatitis C. Clin Gastroenterol Hepatol 3 (2005) 604-609